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Reconstruction of Unobserved States
qPCR: Quantitative PCR
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ARRIETA ET AL 425Background: Asthma is the most prevalent chronic disease of
childhood. Recently, we identified a critical window early in the
life of both mice and Canadian infants during which gut
microbial changes (dysbiosis) affect asthma development. Given
geographic differences in human gut microbiota worldwide, we
studied the effects of gut microbial dysbiosis on atopic wheeze in
a population living in a distinct developing world environment.
Objective: We sought to determine whether microbial
alterations in early infancy are associated with the development
of atopic wheeze in a nonindustrialized setting.
Methods: We conducted a case-control study nested within a
birth cohort from rural Ecuador in which we identified 27
children with atopic wheeze and 70 healthy control subjects at
5 years of age. We analyzed bacterial and eukaryotic gut
microbiota in stool samples collected at 3 months of age using
16S and 18S sequencing. Bacterial metagenomes were predicted
from 16S rRNA data by using Phylogenetic Investigation of
Communities by Reconstruction of Unobserved States and
categorized by function with Kyoto Encyclopedia of Genes and
Genomes ontology. Concentrations of fecal short-chain fatty
acids were determined by using gas chromatography.
Results: As previously observed in Canadian infants, microbial
dysbiosis at 3 months of age was associated with later
development of atopic wheeze. However, the dysbiosis in
Ecuadorian babies involved different bacterial taxa, was more
pronounced, and also involved several fungal taxa. Predicted
metagenomic analysis emphasized significant dysbiosis-
associated differences in genes involved in carbohydrate and
taurine metabolism. Levels of the fecal short-chain fatty acids
acetate and caproate were reduced and increased, respectively,
in the 3-month stool samples of children who went on to have
atopic wheeze.
Conclusions: Our findings support the importance of fungal and
bacterial microbiota during the first 100 days of life on the
development of atopic wheeze and provide additional support
for considering modulation of the gut microbiome as a primary
asthma prevention strategy. (J Allergy Clin Immunol
2018;142:424-34.)
Key words: Asthma, atopy, wheeze, gut microbiome, mycobiome,
short-chain fatty acids, nonindustrialized setting
Asthma is a disease of the airways that affects more than 235
million persons worldwide,1 causing an enormous burden of
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since the 1960s, making it the most common chronic disease of
childhood.1,2 The increase in prevalence has been attributed
primarily to environmental alterations rather than changes in
genetic susceptibility.2 Epidemiologic studies have revealed
several potentially protective environmental factors, such as
growing up on a farm, vaginal birth, breast-feeding, the presence
of household pets, birth order, and number of children, as well an
increased risk of asthma being associated with antibiotic use
during late pregnancy and the first year of life.3 The nature of
these exposures has led many to hypothesize that microbial
alterations (dysbiosis) driven by these factors and leading to
modulation of the infant immune response are causally related
to the increase in asthma and other atopic diseases.
Previously, we provided strong support for this hypothesis in
mice4-6 and human subjects,7,8 in which we found a critical
window early in life during which changes in the gut microbiome
are influential in immune dysregulation and can lead to atopy and
asthma.9 Importantly, we identified specific bacterial taxa
associated with reduced asthma risk in a prospective longitudinal
cohort study of Canadian babies (Canadian Healthy Infant
Longitudinal Development [CHILD] study).10 These microbial
taxa were not only associated with disease but also implicated
causally in ameliorating experimental asthma in amurinemodel.7
A more recent microbiome study in a US pediatric cohort also
showed bacterial dysbiosis in 1-month-old infants at high risk
of asthma.11 Interestingly, this study also measured the fecal
fungal community and found several fungal taxa also involved
in the gut dysbiosis associated with asthma.11 Traditionally not
included in microbiome studies, fungi are important members
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life.11
Because asthma rates continue to climb in affluent countries,
the less developed regions of the world are now also experiencing
increases in asthma prevalence, particularly urban and urbanizing
populations. The International Study of Asthma and Allergies in
Childhood12,13 reported asthma prevalence worldwide and
showed that some of the highest rates were in Latin American
countries, such as Peru, Brazil, and Costa Rica. Although this
has been taken as evidence against the hygiene hypothesis, rural
populations within these countries have lower rates of asthma
than urban populations, and rural-to-urban migration and
modernization can contribute to increases in asthma prevalence.14
Thus changes in microbial exposure driven by urbanization might
help explain regional differences in asthmawithin Latin America.
The intestinal microbiome differs by geographic location, which
is likely explained by differences in diet, lifestyle, and
environmental exposures.15 Not surprisingly, the limited data
available on the microbiome of Latin Americans show notable
differences between the gut microbiome from this part of theworld
and North American or European populations.15,16 Given what we
have reported previously in Canadian infants, we explored whether
similar patterns can be observed in a geographically distinct
population with similar reported rates of asthma prevalence to
Canada (approximately 10% of the population).17
To do this, we completed a case-control study nested within a
birth cohort from a rural district in a tropical coastal region of
Ecuador, in which we selected children who had atopic wheeze at
5 years of age and healthy control subjects. We compared the
bacterial and fungal microbiomes and levels of short-chain fatty
acids (SCFAs) as a measure of bacterial carbohydrate metabolism
in fecal samples collected at 3 months and contrasted our findings
with those obtained from a Canadian cohort. Here we show that
bacterial and fungal dysbiosis can be detected in early life in
babies who go onto have atopic wheeze in later childhood in a
nonindustrialized setting.METHODS
Study design
We conducted a case-control study nested within the ECUAVIDA birth
cohort study designed to study prospectively the effects of early-life parasite
infections on the development of atopy and allergic diseases. The cohort of
2404 newborns was recruited between 2006 and 2009 in the public hospital
serving the rural district of Quininde, Esmeraldas Province, a tropical region
of coastal Ecuador. Detailed information for the cohort is provided
elsewhere.18 Cases and control subjects were selected from children with a
stool sample collected at 3 months of age. As outlined in more detail below,
cases were defined as children with maternally reported wheeze in the
previous 12 months at 5 years of age and with evidence of atopy based on a
positive skin prick test response. Healthy control subjects were a random
sample of children with no previous history of wheeze and no evidence of
atopy at 5 years of age selected by using the sample option in Stata 11 software
(StataCorp, College Station, Tex). The study protocols were approved by the
Ethics Committees of the Hospital Pedro VicenteMaldonado and Universidad
San Francisco, Quito, Ecuador. The study is registered as an observational
study (ISRCTN41239086). Informed written consent was obtained from the
child’s mother.Data collection and study procedures
Data on wheezing were collected by using maternal questionnaires
administered by a trained physician (M.E.C. and M.V.). Wheeze was definedas any episode of reported wheeze during the previous 12 months. Other data
were collected by using periodic questionnaires administered during the first
2 weeks of life and then at 7 and 13 months. Blood was collected at 7 and
13 months and analyzed for eosinophil counts by using standard methods.
Stool samples were collected from the child at 3months and analyzed by using
microscopic methods, as previously described.19 An aliquot was stored at
2808C until analysis.
Atopy was measured based on skin prick test reactivity at 5 years of age using
9 common allergen extracts (Greer Laboratories, Lenoir, NC): Dermatopha-
goides pteronyssinus/farinaemix,American cockroach (Periplaneta americana),
cat, dog, grass pollen (9 southern grass mix), fungi, egg, milk, and peanut, with
positive histamine and negative saline controls. A positive reaction was defined
as a mean wheal diameter of at least 3 mm greater than that elicited by the saline
control, and a positive skin prick test responsewasdefined as a positive reaction to
any of the allergens tested. No children were taking antihistamines at the time of
skin testing.
Microbial community analysis
Extraction and amplicon preparation. DNAwas extracted
from approximately 50 mg of stool. Samples were mechanically lysed by
using Mo Bio dry bead tubes (Mo Bio Laboratories, San Diego, Calif) and the
FastPrep Homogenizer (FastPrep Instrument; MP Biomedicals, Santa Ana,
Calif) before DNA extraction with the Qiagen DNA Stool Mini Kit (Qiagen,
Hilden, Germany).
All samples were amplified by means of PCR in triplicate by using
barcoded primer pairs flanking the V4 region of the 16S gene with the
forward primer 59-GTGCCAGCMGCCGCGGTAA–39 and the reverse primer
5-GGACTACHVGGGTWTCTAAT-39, as previously described.20
16S. Each 50 mL of PCR contained 22 mL of water, 25 mL of TopTaq
Master Mix, 0.5mL of each forward and reverse barcoded primer, and 2mL of
template DNA. The PCR program consisted of an initial DNA denaturation
step at 958C for 5 minutes, 25 cycles of DNA denaturation at 958C for
1minute, an annealing step at 508C for 1minute, an elongation step at 728C for
1 minute, and a final elongation step at 728C for 7 minutes. Controls without
template DNA were included to ensure that no contamination occurred.
Amplicons were run on a 2% agarose gel to ensure adequate amplification.
Amplicons displaying bands at approximately 250 bp were purified with the
Illustra GFX PCR DNA Purification Kit (GE Healthcare, Fairfield, Conn).
Purified samples were diluted 1:50 and quantified with PicoGreen (Invitrogen,
Carlsbad, Calif) in the TECAN M200 (excitation at 480 nm and emission at
520 nm).
18S. DNA was sent to Integrated Microbiome Resource at Dalhousie
University (Halifax, Nova Scotia, Canada) for amplification and sequencing.
The 18S gene was amplified with the primers E572F (59-CYGCGGTAATTC
CAGCTC-39) and E1009R (59-AYGGTATCTRATCRTCTTYG-39), and the
reaction included a PNA blocking primer to reduce amplification
of mammalian sequences (59-TCTTAATCATGGCCTCAGTT-39). Amplifi-
cation was done in duplicate, with one reaction using undiluted DNA and one
reaction using DNA diluted 1:10 in PCR water. Amplification was done
according to previously described protocols.21
Sequencing. 16S. Each PCR pool was analyzed on the Agilent
Bioanalyzer (Agilent Technologies, Santa Clara, Calif) by using the
High Sensitivity DS DNA assay to determine approximate library fragment
size and to verify library integrity. Pooled library concentrations are
determined by using the KAPA Library Quantification Kit (Illumina,
San Diego, Calif). Library pools are diluted to 4 nmol/L and denatured into
single strands by using fresh 0.2 N NaOH. The final library loading
concentration is 8 pmol/L, with an additional PhiX spike-in of 20%. The
amplicon library is sequenced on the MiSeq by using the 8MiSeq 500 Cycle
V2 Reagent Kit (250 3 2).
18S. PCR products were visualized on E-Gels (Thermo Fisher Scientific,
Waltham, Mass). The PCR product was quantified with the Invitrogen Qubit
with PicoGreen and pooled at equal concentrations, according to the method
of Comeau et al.21 PhiX was spiked in at 5%, and the resulting library was
sequenced at Dalhousie University on the Illumina MiSeq with the 8MiSeq
500 Cycle V2 Reagent Kit (250 3 2).
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filtered by size by using Mothur MiSeq SOP (16S)22 or QIIME (18S).23
Demultiplexed reads were trimmed to a uniform length of 250 bp by using
the FastX Toolkit (http://hannonlab.cshl.edu/fastx_toolkit/) and clustered into
operational taxonomic units (OTUs) by using the Minimum Entropy
Decomposition (MED) method,24 as implemented in the Oligotyping
microbial analysis software package.25 MED is used to perform de novo
taxonomic clustering with Shannon entropy to separate biologically
meaningful patterns of nucleotide diversity from sequencing noise; processed
data are partitioned into phylogenetically homogeneous units (MED nodes)
for downstream bacterial diversity analyses. This analysis was carried out
with the minimum substantive abundance parameter (-M) set at 250 reads.
All other parameters were run with default settings; the maximum variation
allowed per node (-V) was automatically set at 3 nucleotides.
Representative sequences were classified by clustering against the
Greengenes database at 97% similarity (16S)26 or SILVA123 at 99% similarity
(18S).27 The 16S data set was filtered to remove mitochondria and chloroplast
sequences. The 18S data set was filtered to remove mammalian sequences,
plants, and all OTUs present in fewer than 3 samples. After filtering, a cutoff
of 1000 reads per sample was applied. All 16S samples passed the cutoff. In
the 18S data set many samples had fewer than 1000 sequences per sample after
filtering. Thus 10 samples from atopic patients with wheeze (AWs) and 22
control samples were retained for statistical analysis of the 18S data set. It
is important to apply this sequencing cutoff because a low number of
sequences might be a consequence of amplification or sequencing artifacts
that might not reflect a real microbial community and will not provide enough
statistical power for analysis. Singleton OTUs and any OTUs present less than
3 times among all samples were removed from both the 16S and 18S analyses.
We constructed a phylogenetic tree for Pichia species by first extracting
sequences from the aligned 99% SILVA 123 data set that corresponded to
the genus Pichia or to the family Pichiaceae with RAxML.28 The short
Illumina reads were then aligned to the SILVA 123 data set by using
PyNAST29 and placed in the reference Pichia species tree by using the
maximum likelihood RAxML evolutionary placement algorithm.30
Quantitative PCR
Quantitative PCR (qPCR) was performed on genomic DNA isolated from
stool samples by using the QIAamp Fast DNA Stool Mini Kit (Qiagen) to
validate the high-throughput sequencing results. After extraction, all DNA
concentrations weremeasuredwith theQuant-iT PicoGreen dsDNAAssayKit
(Thermo Fisher Scientific), and template DNA used in the qPCR reactionswas
obtained from stocks normalized to 1 or 0.2 ng/mL (samples 2, 7, 11, 12, 14,
28, 54, 56, 59, 61, 66, 67, 71, 73, 79, and 93) and diluted as necessary.
Pichia kudriavzevii–specific primers targeting the 18S rRNA gene of this
organism (forward: 59-CAT TCC GGG GGG CAT GCC T-39 and reverse:
59-GGC CAG CTT CGC TCC CTT TCA-39) and fungi-specific 18S primers
(FR1: 59-AIC CAT TCA ATC GGT AIT-39 and FF390: 59-CGA TAA CGA
ACG AGA CCT-39)31 were used to measure the absolute abundance of
P kudriavzevii and fungal 18S gene copies, respectively, by using the absolute
quantification method. Primers for P kudriavzevii were designed by using
CLUSTALW and National Center for Biotechnology Information Primer
BLAST software, and their specificity for P kudriavzevii was verified by
sequencing the amplicons obtained from a PCR reaction done with genomic
DNA combined from 5 chosen subjects shown to be enriched in P kudriavzevii
based on the sequencing data.
qPCR standard curve generation. 18S standard curves (see
Fig E1 in this article’s Online Repository at www.jacionline.org) were gener-
ated by using 1:5 dilutions of a 1 ng/mL stock of 18S amplicons obtained from
PCR reactions done with the fungi-specific 18S primers (FR1 and FF390) and
purified P kudriavzevii template DNA. Template DNAwas extracted by using
the YeaStar Genomic DNA Kit (Zymo Research, Irvine, Calif) from pure
liquid cultures (ATCC 6258) grown for 24 hours at 308C in YPD media.
A P kudriavzevii standard curve was generated by performing 1:5 dilutions
of a 1 ng/mL stock of the same purified P kudriavzevii DNA (see Fig E1).
qPCR reactions. All qPCR reactions were performed in duplicate on
all stool samples for which there was sufficient DNA (n 5 95; samples 3 and19 were not included) by using the 7500 Fast Real-Time System (Applied
Biosystems, Foster City, Calif). Each 10-mL qPCR reaction done with the
P kudriavzevii–specific primers contained 5 mL of iQ SYBR Green Supermix
(Bio-Rad Laboratories, Hercules, Calif), 0.5 mL of each of the forward and
reverse primers, and 4 mL of 0.2 ng/mL template DNA. The qPCR program
consisted of 2 initial steps of 20 seconds at 558C and 10 minutes at 958C,
followed by 40 cycles of 30 seconds at 958C and 60 seconds at 608C and a final
cycle of 958C at 15 seconds, 608C at 1 minute, 958C at 15 seconds, and 608C at
15 seconds.
Each 20-mL reaction used for 18S rDNA quantitation contained 10 mL of
iQ SYBR Green Supermix, 2.5 mL of each of the FR1 and FF390 primers,
3 mL of nuclease-free water, and 2 mL of 1 ng/mL genomic DNA. The qPCR
program consisted of an initial step at 958C for 10 minutes, followed by 40
cycles of 15 seconds at 958C, 30 seconds at 508C, and 60 seconds at 708C, with
a final cycle of 958C at 15 seconds, 608C at 1 minute, 958C at 15 seconds, and
608C at 15 seconds.
Phylogenetic Investigation of Communities by
Reconstruction of Unobserved States
We used Phylogenetic Investigation of Communities by Reconstruction of
Unobserved States (PICRUSt)32 to generate a profile of putative functions
(through metagenomic prediction) from the 16S rRNA OTU data. Predicted
metagenomes from all samples were categorized by function at Kyoto
Encyclopedia of Genes and Genome orthology level 3. To test for significant
differences in functional category abundances between the AW and control
samples, we used theWelch t test implementation of STAMP.33We also tested
for differentially abundant predicted genes with DESeq234 under default
settings. DESeq2 estimates variance and mean dependence in count data
from high-throughput data sets and tests for a differential expression based
on a model using negative binomial distribution. The test statistics’ P values
were adjusted for multiple testing by using the procedure of Benjamini and
Hochberg (false discovery rate threshold, 5%).SCFA analysis
Infants’ fecal samples were combined with 25% phosphoric acid,
vortexed, and centrifuged until a clear supernatant was obtained.
Supernatants were submitted for gas chromatography to the Department of
Agricultural, Food and Nutritional Science of the University of Alberta
(Edmonton, Alberta, Canada). Samples were analyzed, as previously
described,35 with modifications. Briefly, samples were combined with
4-methyl-valeric acid as an internal standard, and 0.2 mL was injected into
the Bruker SCION 456 gas chromatograph by using a Stabilwax-DA
30-m 3 0.53-mm 3 0.5-mm column (Restek, Bellefonte, Pa). A standard
solution containing acetic acid, proprionic acid, isobutyric acid, butyric
acid, isovaleric acid, valeric acid, and caproic acid, combined with internal
standard, was injected in every run.
Programmable temperature vaporization injector and flame ionization
detector temperatures were held at 2508C for the entire run. The oven was
started at 808C and immediately ramped to 2108C at 458C/min, where it was
held for 5.11 minutes. Total run time was 8.00 minutes. Helium was used at a
constant flow of 20.00mL/min. Sample concentrations were normalized to the
wet weight of feces.Statistical analysis
Differences in frequencies in categorical and continuous variables between
cases and control subjects were evaluated by using x2 and Mann-Whitney
tests, respectively. The Fisher exact test was used for the reduced sample
available for fungal sequencing analysis. We assessed fecal microbial
diversity and relative abundance of bacterial and fungal taxa by using
phyloseq,36 along with additional R-based computational tools37-42 in Rstudio
software. Principal coordinates analysis was conducted by using phyloseq
(Bray-Curtis as distance metric) and statistically confirmed with
permutational multivariate ANOVA. The Chao1 index was calculated by
using phyloseq and statistically confirmed with the Mann-Whitney test
TABLE I. Characteristics of AWs and healthy control subjects







Male 13 (48%) 32 (46%) .829
Female 14 (52%) 38 (54%)
Breast-feeding
No 1 (4%) 1 (1%) .494
Yes 26 (96%) 69 (89%)
Period breast-feeding (mo)
Median (range) 13 (4-20) 12 (3-24) .510
Type of delivery
Vaginal 17 (63%) 59 (84%) .022
Caesarean 10 (37%) 11 (16%)
Birth order
First 9 (33%) 23 (33%) .964
Second to third 11 (41%) 27 (39%)
>_Fourth 7 (26%) 20 (28%)
Household
Maternal educational status
Illiterate 1 (4%) 7 (10%) .119
Primary complete 21 (78%) 41 (59%)
Secondary complete 5 (18%) 22 (31%)
Socioeconomic level
Low 10 (37%) 26 (37%) .994
Medium 9 (33%) 24 (34%)
High 8 (30%) 20 (29%)
Agricultural activities
No 13 (48%) 34 (49%) .970
Yes 14 (52%) 36 (51%)
Potable water
No 15 (56%) 52 (74%) .074
Yes 12 (44%) 18 (26%)
Bathroom
Latrine/field 18 (67%) 44 (63%) .992
WC 9 (33%) 26 (37%)
Antibiotics and infections
Antibiotics
Maternal antibiotics in pregnancy
No 9 (33%) 35 (50%) .139
Yes 18 (67%) 35 (50%)
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The R packages DESeq234 and multivariate association with linear models
(MaAsLin)43 were used to calculate differentially abundant OTUs between
the control and AW samples. From the available metadata, the following
covariates were forced into the MaAsLin model based on significant
associations with the 5-year AW phenotype and on previously reported
associations with asthma or with microbiome shifts: antibiotic use during
pregnancy or the first year of life, duration of antibiotic use during pregnancy
or the first year of life, type of delivery, household potable water, number of
respiratory tract infections during the first year of life, eosinophilia at
7 months, and number of diarrheal episodes during the first year of life. All
ecological measurements, except for the Chao1 index, were performed on
the 100 most abundant OTUs after normalizing OTUs for relative abundance,
which represent 98.14% and 99.83% of total OTUs in the 16S and 18S data
sets, respectively.
RESULTS
Study subject characteristics: AWs and control
subjects
From 1066 stool samples collected from infants in the
ECUAVIDA cohort at 3 months of age with follow-up data at
5 years of age (2090), we identified 27 AWs and a random sample
of 70 healthy control subjects with no history of wheeze and no
atopy at 5 years. The required sample size for microbiome
analysis was determined by using MetSizeR, a software package
designed to estimate sample size for high-throughput
experiments. Assuming at least 100 parameters measured and
that 10% would differ significantly between cases and control
subjects, a sample size of 24 was required to maintain a false
discovery rate of less than 0.05. Characteristics of AWs and
control subjects are shown in Table I. Most variables were
distributed similarly between the 2 groups with the exceptions
of mode of delivery (caesarean delivery: 37% for AWs vs 16%
for control subjects, P 5 .022) and number of documented acute
respiratory tract infections, which were more frequent in AWs
compared with control subjects (P 5 .011). There were no
significant differences with respect to baseline characteristics
between AWs included in this analysis and those not included
for lack of a 3-month stool sample (see Table E1 in this article’s
Online Repository at www.jacionline.org).Period (d)
Median (IQR) 10 (3-21) 7 (1-48) .113
During first year of life (courses)
0 14 (52%) 41 (59%) .196
1 11 (41%) 17 (24%)
2-4 2 (7%) 12 (17%)
Infections during first year
Acute respiratory (episodes)
0 0 (0%) 2 (3%) .011
1 3 (26%) 35 (50%)
2 11 (41%) 27 (38%)
3-5 9 (33%) 6 (9%)
Acute diarrhea
No 13 (48%) 33 (47%) .929
Yes 14 (52%) 37 (53)
Text in boldface denotes statistical significance (P < .05). IQR, Interquartile range.Bacterial and fungal alterations associated with AW
phenotype
As expected, the gut microbiome between 3-month-olds in the
Canadian CHILD Study and ECUAVIDA study differed
substantially (see Fig E2 in this article’s Online Repository at
www.jacionline.org). In line with what we reported previously
in Canadian infants, the AW phenotype did not explain any
significant changes in a or b bacterial diversity (Mann-Whitney
and permutational multivariate ANOVA, respectively; see
Fig E3, A and B, in this article’s Online Repository at
www.jacionline.org). In addition to the bacterial profile, we also
sequenced the V4 region of the 18S rRNA gene to obtain a profile
of the intestinal eukaryotic microbiome in these infants. After
subtracting plant and human sequences, our analysis found only
sequences of fungal origin in the fecal microbiome of these
3-month-old babies. In this data set many samples had fewer
than 1000 sequences per sample after applying filtering steps,
which prompted their removal from the data set. Thus only
10 AW and 22 control samples were retained for statistical
analysis of the 18S data set. However, AWs and control subjectsused for fungal sequence analysis were reasonably representative
of the original case and control samples (see Table E2 in this
article’s Online Repository at www.jacionline.org).
Similar to the 16S analysis, no significant differences were
found in fungal a or b diversity between infants with atopic
wheeze and control subjects (see Fig E3, C and D). Despite the
FIG 1. Bacterial dysbiosis associated with development of atopic wheeze. A, Relative abundance of
bacterial genera within the top 100 OTUs among the 2 phenotypes at 3 months. Rectangle colors
correspond to the bacterial genera in the legend. Rectangles represent merged OTUs belonging to the
same genus. NA, OTUs without genus-level taxonomic assignment. B, Log fold change of OTUs that are
significantly (false discovery rate < 0.05) abundant between AWs and control subjects calculated by using
DESeq2. Error bars denote SDs. Taxonomic identification and OTU numbers are denoted on the y-axis.
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control subjects, several OTUs of bacteria (Fig 1) and especially
fungi (Fig 2) were found to be differentially abundant by using
DESeq2, a method of differential analysis of high-throughput
sequencing data based on a model of negative binomial
distribution. Among the observed bacterial alterations were 2
OTUs identified as Veillonella species, 3 OTUs identified a
Streptococcus species, 1 OTU identified as Bacteroides species,
1 OTU identified as Ruminococcus gnavus, and 1 OTU identified
as Bifidobacterium species (DESeq2; P < .05, Wald test and false
discovery rate). Interestingly, 5 of these OTUs were among the
top 10 most abundant bacterial OTUs in the data set. Notably,
more than twice number of fungal OTUs (19) were significantly
different between AWs and control subjects compared with
bacterial OTUs, with 7 of them identified as the yeast
P kudriavzevii (Fig 2, B). The larger differences in the fungal
versus bacterial microbiome were also evident in relative
abundance plots of the top 100most abundant bacterial and fungal
taxa, organized by genus (Figs 1, A, and 2, A). Additionally, we
found several correlations between bacterial and fungal OTUs,
suggesting potential ecologic synergistic and antagonistic
associations occurring in the infant gut (see Fig E4 in this article’s
Online Repository at www.jacionline.org).Given extensive metadata collected in this cohort, we captured
the effect of the gut microbiome on the atopic wheeze phenotype
(used as a surrogate for asthma risk) while controlling for
potential confounding using MaAsLin.43 MaAsLin is a
multivariate linear modeling tool with boosting that tests for
associations between specific microbial taxa and continuous
and/or Boolean metadata. In microbiome studies certain
variables, such as diet, age, and sample origin, can have large
effects on microbiome composition. Thus it is important to
subtract their influence from the potential effect caused by other
metadata in the study, such as the phenotype. With MaAsLin,
we found a significant association between most of the
differential taxa obtained through DESeq2 analysis and atopic
wheeze, including the bacterial genera Bifidobacterium,
Streptococcus, andVeillonella, as well as the fungiP kudriavzevii,
Saccharomyces, and Saccharomycetales (see Tables E3 and E4
in this article’s Online Repository at www.jacionline.org),
supporting the strong association between these microbial
changes and the phenotype. By using both statistical approaches,
it was evident that fungal alterations were more marked than
bacterial dysbiosis.
Because of the strength of the association between the yeast
P kudriavzevii and atopic wheeze risk, we validated the
FIG 2. Fungal dysbiosis associated with development of atopic wheeze. A, Relative abundance of fungal
genera within the top 100 OTUs among the 2 phenotypes at 3 months. Rectangle colors correspond to
fungal genera in the legend. Rectangles represent merged OTUs belonging to the same genus or higher
taxa if genus information was not obtained in the analysis. NA, OTUs without genus-level taxonomic
assignment. B, Log fold change of OTUs significantly (false discovery rate < 0.05) abundant between
AWs and control subjects calculated by using DESeq2. Error bars denote SDs. Taxonomic identification
and OTU numbers are denoted on the y-axis.
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sequences assigned as P kudriavzevii into a phylogenetic tree of
all sequences assigned to Pichia species yeast in the reference
database and found that all of the OTUs fell within the
P kudriavzevii clade (see Fig E5 in this article’s OnlineRepository at www.jacionline.org). We further validated this
result by designing and optimizing specific primers for this yeast.
Using qPCR on all AW and control samples, we confirmed
the increased prevalence of Pichia species in the stool of
3-month-old babies who went on to have atopic wheeze in this
FIG 3. Fungus-specific qPCR and Illumina sequence data. A, qPCR quantification (standard curve method)
of P kudriavzevii in feces of 3-month-old infants from the ECUAVIDA study (control subjects, 68; AWs, 27).
B, Relative abundance of fungal reads over the total number of eukaryotic reads from 18S data set. Only
samples with more than 1000 sequences after filtering were included in the 18S high-throughput
sequencing analysis (control subjects, 23; AWs, 10). C, qPCR quantification (standard curve method) of
fungus-specific 18S copies in feces of 3-month-old infants from the ECUAVIDA study (control subjects,
68; AWs, 27). In Fig 3, A and C, graphs are based on a logarithmic scale. All graphs show Mann-Whitney
tests: *P < .05 and ***P < .001.
FIG 4. Concentration of the 6 most abundant SCFAs in feces of infants with atopic wheeze and control
infants at 3 months of age measured by using gas chromatography and normalized to feces wet weight.
Acetate (A), butyrate (B), propionate (C), isobutyrate (D), valerate (E), and caproate (F). (AWs, 27; control
subjects, 70; *P < .05 and **P < .01, Mann-Whitney test).
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between groups, almost a third of child AWs (8/27) had a higher
abundance of P kudriavzevii than the highest abundance among
control subjects (P 5 .001).
In addition, we found that AW samples contained a higher
proportion of fungal reads over all eukaryotic reads (Fig 3, B). To
confirm this bioinformatic observation, we quantified total fungal
18S rRNA gene copies using qPCR in all samples. Notably, we
found a small yet significant increase in 18S rRNA gene copiesin the AW samples (Fig 3, C), suggesting that fungi are
overrepresented in the gut microbiome of babies who go on to
have atopic wheeze.Functional microbiome alterations in babies who
had atopic wheeze
To determine the functional potential of the bacterial dysbiosis
detected by using 16S sequencing, we predicted the microbiome
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method that predicts functional composition based on the 16S
rRNA gene content and copy number and reference bacterial
genomes. By comparing the predicted genetic composition be-
tween the 2 groups, we found taurine and hypotaurine metabolism,
polyketide sugar unit biosynthesis, and carbohydrate digestion and
absorption pathways were decreased in AWs (Welch t test, see Fig
E6 in this article’s Online Repository at www.jacionline.org).
We investigated further the predicted change in bacterial
carbohydrate metabolism by measuring SCFA concentrations in
feces. Similar to what we found in babies from the CHILD study,
there was a significant decrease in acetate concentrations in the
stool of babies in the ECUAVIDA study who went on to have
atopic wheeze (Fig 4, A), suggesting similar gut bacterial
fermentation patterns between the 2 populations. In addition,
we detected an increase in caproate levels associated with the
AW phenotype in this cohort (Fig 4, F).DISCUSSION
In the present study we explored the association between gut
bacterial and fungal dysbiosis in infancy and the development of
atopic wheeze in later childhood in a representative sample of an
Ecuadorian birth cohort (ECUAVIDA), which has studied a
population living in a rural district in a tropical nonindustrialized
country. This represents a distinct environment from all previous
studies of the effects of the microbiome on asthma development
done in developed settings. In agreement with previous analyses
from Canadian7,8 and US11 birth cohorts, our findings provide
further confirmation of the presence of a microbial signature in
the first 100 days of life associated with pediatric risk. A direct
comparison between these new findings and the dysbiosis present
in the Canadian CHILD study is not entirely possible because of
differences in study design. In the CHILD study atopic wheeze
was defined at 1 year of age, whereas this study measured atopic
wheezing at 5 years as a surrogate for asthma risk. However, the
observed differences in gut dysbiosis associated with the risk of
atopic wheezing in both cohorts could also originate from
differences in gut microbial composition, given that the micro-
biome of babies in ECUAVIDA differed substantially from that
in age-matched Canadian babies in the CHILD study. As has
been shown previously,44 modernization processes (or westerni-
zation) strongly affect the human gut microbiome. Although
this study was not designed to study the factors that lead to
such differences, the humid warm weather in this region and
less hygienic conditions are likely to increase exposures to mi-
crobes, including those that cause childhood infectious diseases,
which might affect health and modify the infant microbiome.14,45
The differences in the gut microbiome detected in this cohort
yielded important information. First, the microbial signature
associated with atopic wheeze in these infants was more
pronounced than in the Canadian cohort. In addition, except for
Veillonella species, the bacterial dysbiosis associated with atopic
wheezing in this cohort involved different taxa to those detected
in the Canadian study. Despite major compositional differences
associated with atopic wheezing between the Canadian and
Ecuadorian cohorts, we found important metabolic similarities
between the 2 cohorts. Notably, a decrease in fecal acetate in
atopic infants with wheeze was a common finding in the 2
populations, suggesting that alterations in fermentative patterns
that led to a decrease in acetate production might be a commonfeature associated with atopic wheezing. A reduction in
carbohydrate metabolism predicted by PICRUSt also supports
the association between SCFA production and atopic wheeze.
Acetate,46 butyrate,47 and propionate46 have been shown to
stimulate regulatory T-cell proliferation and attenuate
allergy-associated TH2 immune responses.
48 Given our data in
2 very different cohorts, fecal acetate levels reductions should
be studied further in larger longitudinal cohorts as a possible
biomarker of asthma risk in young babies.
Prompted by the results from a recent study in US infants,11 we
profiled the eukaryotic microbiome of the Ecuadorian babies
using the 18S rRNA marker gene and a custom-annotated
taxonomic database. Interestingly, after removing mammalian
and plant-derived sequences, only fungal sequences remained in
the data set. Given that we have successfully detected other
eukaryotic commensals using the same methodological approach
in adult human cohorts (data not shown), this finding indicates
that the eukaryotic microbiome in early life consists mainly of
fungi, at least in this population. Filamentous fungi and yeasts
are common members of the normal gut microbiome, although
in a much smaller proportion than bacteria.49 However, it has
been reported that during the first 3months of life, they are present
at a significantly higher diversity than later in life.11 Furthermore,
their role in immune regulation and asthma development has been
documented previously in relevant models of murine lung
inflammation. In particular, modulation of the mycobiome has
been shown to increase the severity of murine lung
inflammation.50Moreover, antibiotic-induced blooms ofCandida
species were associated with increased experimental murine lung
inflammation.51,52 This effect has been shown to be mediated by
Candida species–produced prostaglandin E2,
53-55 an arachidonic
acid derivative known play an important role in orchestrating
immune interactions relevant in asthmatic patients.
Among the 19 fungal OTUs associated with the AW phenotype
(twice as many as the differential bacterial OTUs detected), 7 of
them corresponded to the yeast P kudriavzevii. The robustness of
the statistical association between this yeast and the AW
phenotype prompted us to further validate and confirm its
taxonomic identity bioinformatically and through qPCR,
especially given the reduced sample size used in the 18S
sequencing analysis. We note that there is sufficient variation in
this 18S region to identify Pichia species and distinguish between
relatives.56 P kudriavzevii has been described as a commensal
member of the gut mycobiome,57 and to our knowledge, this is
the first report of this species implicated in gut microbial
dysbiosis associated with atopic disease. Notably, qPCR analysis
in all the samples detected not only an increase in P kudriavzevii
but also an increase in fungi-specific 18S gene copies, suggesting,
also for the first time, that fungal overrepresentation in the infant
gut microbiome is associated positively with the development of
atopic wheeze. However, given the size of the sample studied and
the small but significant differences detected in fungal gene
copies and reads, caution should be taken when extrapolating
these findings to other populations. These findings should be
replicated in other human cohorts before considering gut fungal
overrepresentation, as associated with asthma risk.
Evidently, fungal dysbiosis was more pronounced than
bacterial dysbiosis in this study. Thus the role of P kudriavzevii
and other yeasts should be explored in mechanistic studies using
animal models. In addition to being important members of the gut
microbiome, fungal species can experience an ecological
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risk factor associated with asthma development in most human
cohorts.3
Collectively, these data support our previously proposed
concept of a critical window in early life during which microbial
dysbiosis can be detected in strong association with a subsequent
allergic phenotype predictive of asthma.9 The nature of this
dysbiosis appears to reflect the microbiome composition in a
given population, prompting additional analysis in prospective
studies around the world and inclusion of fungal analyses in all
microbial surveys. Optimized biomarker studies of the microbial
taxa and the metabolites involved in regional asthma-associated
dysbiosis could help identify infants at risk of asthma before
symptoms occur, as well as provide a scientific rationale for future
therapeutic strategies aimed at restoring an altered infant gut
microbiome.
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Clinical implications: Our findings support the importance of
early-life infant gut microbial dysbiosis in the development of
atopic wheeze and could be used for the development of novel
asthma primary prevention strategies through modification of
the microbiome in early life.REFERENCES
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FIG E1. Standard curves for fungus-specific 18S (A) and P kudriavzevii
(B) qPCR reactions. Standard curves were generated by using 1:5 dilutions
of a 1 ng/mL stock of 18S amplicons obtained from PCR reactions done with
fungus-specific 18S primers (FR1 and FF390) and purified P kudriavzevii
template DNA (see the Methods section). DNA concentrations are denoted
in logarithmic scale (y-axis) in relation to PCR cycle number (x-axis).
Exponential trend lines and equations, as well as R2 values, are included
in each graph.
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FIG E2. Relative abundance of the 100 most abundant bacterial OTUs in feces of Canadian versus
Ecuadorian 3-month-old infants. Rectangle colors correspond to the bacterial genera in the legend.
Rectangles represent merged OTUs belonging to the same genus. NA, OTUs without genus-level
taxonomic assignment.
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FIG E3. Both a (A and C; Chao1 index) and b (B and D; principal coordinates analysis [Bray-Curtis]) bacterial
(Fig E3, A and B) and fungal (Fig E3, C and D) diversity in fecal samples from 3-month-old infants who
presented with atopic wheeze at 5 years (AW) versus healthy control subjects (CTRL). Sequencing results
from all 16S samples and from 33 18S samples (control subjects, 23; AWs, 10) were retained after applying
a cutoff of 1000 sequences per sample. The atopic wheeze phenotype did not explain significant changes in
these measurements (P 5 .323 and .676 [Mann-Whitney test and permutational multivariate ANOVA] for
Fig E3, A and C, respectively).
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FIG E4. Heat map of biweight correlations between the top 100 bacterial (x-axis) and top 100 fungal (y-axis)
OTUs in 33 fecal samples (control subjects, 23; AWs, 10) from 3-month-old infants recruited in the
ECUAVIDA cohort study. Significant correlation values are denoted with a cross (P < .05, false discovery
rate).
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FIG E5. Phylogenetic placement of P kudriavzeviiOTUs within Pichia species sequences from the SILVA 123
reference database. 18S ribosomal DNA sequences labeled as Pichia species or Pichiaceae in the 99% SILVA
reference database were aligned and then used to construct a reference tree with RAxML. OTUs from this
study assigned to Pichia species were placed in this tree with the RAxML evolutionary placement algorithm.
All OTUs cluster within a clade of P kudriavzevii.
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FIG E6. PICRUSt-predicted Kyoto Encyclopedia of Genes and Genomes functional categories with
significant differences in relative abundance between control subjects and AWs (Welch t test, q values
are shown in figure).
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TABLE E1. Characteristics of AWs at 5 years comparing those included in the analysis with those excluded from the analysis
Variable Included (n 5 27) Excluded (n 5 32) P value
Child
Sex
Male 13 (48%) 21 (66%) .176
Female 14 (52%) 11 (34%)
Breast-feeding
No 1 (4%) 0 (0%) .280
Yes 26 (96%) 32 (100%)
Period breast-feeding (mo)
Median (range) 13 (4-20) 13 (10-18) .948
Type of delivery
Vaginal 17 (63%) 23 (72%) .465
Caesarean 10 (37%) 9 (28%)
Birth order
First 9 (33%) 6 (19%) .230
Second to third 11 (41%) 14 (44%)
>_Fourth 7 (26%) 12 (37%)
Household
Maternal educational status
Illiterate 1 (4%) 4 (12%) .083
Primary complete 21 (78%) 16 (50%)
Secondary complete 5 (18%) 12 (38%)
Socioeconomic level
Low 10 (37%) 9 (28%) .529
Medium 9 (33%) 9 (28%)
High 8 (30%) 14 (44%)
Agricultural activities
No 13 (48%) 15 (47%) .922
Yes 14 (52%) 17 (53%)
Potable water
No 15 (56%) 21 (66%) .429
Yes 12 (44%) 11 (34%)
Bathroom
Latrine/field 17 (63%) 23 (72%) .465
WC 10 (37%) 9 (28%)
Antibiotics and infections
Antibiotics
Maternal antibiotics in pregnancy
No 9 (33%) 14 (44%) .414
Yes 18 (67%) 18 (56%)
Period (d)
Median (IQR) 10 (3-21) 8 (5-10) .101
During first year of life (courses)
0 14 (52%) 18 (56%) .455
1 11 (41%) 9 (28%)
2-4 2 (7%) 5 (16%)
Infections during first year
Acute respiratory (episodes)
0 0 (0%) 2 (6%) .597
1 3 (26%) 9 (28%)
2 11 (41%) 12 (38%)
3-5 9 (33%) 9 (28%)
Acute diarrhea
No 13 (48%) 12 (38%) .410
Yes 14 (52%) 20 (62%)
Inclusion in the analysis was based on having a stool sample collected at 3 months of age.
IQR, Interquartile range.
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TABLE E2. Characteristics of study subjects in a reduced cohort for whom fungal sequencing data were analyzed
Variable AWs (n 5 10) Control subjects (n 5 22) P value
Child
Sex
Male 7 (70%) 11 (50%) .253
Female 3 (30%) 11 (50%)
Breast-feeding
No 0 (0%) 0 (0%) —
Yes 10 (100%) 22 (100%)
Period breast-feeding (mo)
Median (range) 14 (9-16) 13 (12-16) .962
Type of delivery
Vaginal 7 (70%) 18 (82%) .376
Caesarean 3 (30%) 4 (18%)
Birth order
First 5 (50%) 7 (32%) .412
Second to third 2 (20%) 9 (41%)
>_Fourth 3 (30%) 6 (27%)
Household
Maternal educational status
Illiterate 0 (0%) 1 (5%) .358
Primary complete 9 (90%) 14 (64%)
Secondary complete 1 (10%) 7 (32%)
Socioeconomic level
Low 2 (20%) 10 (45%) .318
Medium 3 (30%) 7 (32%)
High 5 (50%) 5 (23%)
Agricultural activities
No 6 (60%) 10 (45%) .352
Yes 4 (40%) 12 (55%)
Potable water
No 4 (40%) 13 (59%) .267
Yes 6 (60%) 9 (41%)
Bathroom
Latrine/field 8 (80%) 16 (73%) .512
WC 2 (20%) 6 (27%)
Antibiotics and infections
Antibiotics
Maternal antibiotics in pregnancy
No 3 (30%) 13 (59%) .126
Yes 7 (70%) 9 (41%)
Period (d)
Median (IQR) 7 (0-9) 0 (0-5) .109
During first year of life (courses)
0 7 (70%) 12 (55%) .631
1 3 (30%) 8 (36%)
2-4 0 (0%) 3 (13%)
Infections during first year
Acute respiratory (episodes)
0 0 (0%) 1 (5%) .12
1 3 (30%) 14 (63%)
2 4 (40%) 6 (27%)
3-5 3 (30%) 1 (5%)
Acute diarrhea
No 5 (50%) 10 (45%) .81
Yes 5 (50%) 12 (55%)
IQR, Interquartile range.
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TABLE E3. Differentially abundant microbial OTUs (false discovery rate < 0.05) between AWs and control subjects calculated by
using DESeq2
Variable Feature log2 Fold change P value (adjusted) Effect 95% CI
Bacterial features
Phenotype Otu4_Veillonella 22.5303623 3.98E-11 Increased 22.6510012 to 22.4097234
Phenotype Otu5_Streptococcus 4.56211499 3.98E-11 Decreased 4.34260055 to 4.78162944
Phenotype Otu7_Bacteroides 23.0482054 7.12E-11 Increased 23.1976966 to 22.8987142
Phenotype Otu9_Streptococcus 2.2278997 .00400262 Decreased 2.01960114 to 2.43619825
Phenotype Otu010_Streptococcus 3.27520397 2.04E-05 Decreased 3.04766741 to 3.50274053
Phenotype Otu018_Ruminococcus_gnavus 3.62669523 .00162925 Decreased 3.30974875 to 3.94364171
Phenotype Otu026_Veillonella 2.96323589 .00561369 Decreased 2.67680938 to 3.2496624
Phenotype Otu179_Bifidobacterium 24.510034 2.25E-05 Increased 24.8273551 to 24.1927128
Fungal features
Phenotype 58 __Debaryomyces_hansenii 3.28100437 5.64E-05 Increased 2.77607299 to 3.78593574
Phenotype 558 __Candida_tropicalis 2.89814469 .00031816 Increased 2.39918176 to 3.39710762
Phenotype 638 __uncultured_fungus_Saccharomycetales 3.26985979 .00015227 Increased 2.73474031 to 3.80497926
Phenotype 639__Saccharomycetes 3.33253614 8.21E-05 Increased 2.80805337 to 3.85701891
Phenotype 642 __uncultured_fungus_Saccharomycetales 4.01492817 6.51E-06 Increased 3.46305197 to 4.56680436
Phenotype 643 __uncultured_fungus_Saccharomycetales 3.27079498 .0001125 Increased 2.74586052 to 3.79572945
Phenotype 716 __uncultured_fungus_Saccharomycetales 23.9866517 7.64E-07 Decreased 24.4864069 to 23.4868965
Phenotype 717 __uncultured_fungus_Saccharomycetales 24.048536 5.97E-07 Decreased 24.5511721 to 23.5458998
Phenotype 1269 __uncultured_fungus_Saccharomycetales 3.01162348 .000382 Increased 2.48614246 to 3.5371045
Phenotype 1295 __uncultured_fungus_Saccharomycetales 3.97293655 .00036181 Increased 3.28249384 to 4.66337926
Phenotype 1328__Saccharomyces 22.2265938 .00135391 Decreased 22.6572829 to 21.7959046
Phenotype 1529 __Pichia_kudriavzevii 26.3822352 2.53E-13 Decreased 26.9228509 to 25.8416194
Phenotype 1531 __Pichia_kudriavzevii 23.421152 2.82E-08 Decreased 23.8030808 to 23.0392231
Phenotype 1533 __Pichia_kudriavzevii 23.4287207 2.23E-08 Decreased 23.8086674 to 23.048774
Phenotype 1534 __Pichia_kudriavzevii 23.6780058 1.55E-08 Decreased 24.0810328 to 23.2749788
Phenotype 1538 __Pichia_kudriavzevii 26.3906936 9.03E-13 Decreased 26.9451013 to 25.8362859
Phenotype 1539 __Pichia_kudriavzevii 23.5008997 3.85E-08 Decreased 23.8956113 to 23.1061881
Phenotype 1540 __Pichia_kudriavzevii 23.61174 1.14E-08 Decreased 24.0039118 to 23.2195682
Phenotype 1541 __Pichia_kudriavzevii 21.7264597 .00096672 Decreased 22.0507199 to 21.4021995
P values are corrected for false discovery rate. OTUs in boldface remained statistically significant after controlling for confounding (Table E4).
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TABLE E4. Microbial taxa associated with atopic wheezing corrected for major confounding effects known to affect microbiome
composition by using MaAsLin
Variable Feature Coefficient P value (adjusted) q Value Effect 95% CI
Bacterial features
Phenotype Bifidobacterium_179 0.02299582 1.05E-12 8.64E-11 Increased 0.02169825 to 0.0242934
Phenotype Veillonella_Dispar_132 20.0092217 .00254641 0.10440262 Decreased 20.0106249 to 20.0078185
Phenotype Veillonella_86 20.007847 .02938598 0.6277335 Decreased 20.0094878 to 20.0062061
Phenotype Veillonella_26 20.0167265 .03077532 0.6277335 Decreased 20.0201968 to 20.0132562
Phenotype Streptococcus_135 20.0050144 .0444958 0.6277335 Decreased 20.0071267 to 20.0029021
Phenotype Bifidobacterium_103 0.00845423 .04751864 0.6277335 Increased 0.00639847 to 0.01050998
Fungal features
Phenotype Pichia_Kudriavzevii_1538 20.2039807 .00325965 0.08131335 Decreased 20.2268391 to 0.28743912
Phenotype Pichia_Kudriavzevii_1534 20.035631 .00350364 0.08131335 Decreased 20.0396671 to 0.05036711
Phenotype Pichia_Kudriavzevii_1531 20.0358471 .00431312 0.08131335 Decreased 20.040034 to 0.05113405
Phenotype Pichia_Kudriavzevii_1533 20.0309382 .00496049 0.08131335 Decreased 20.0346121 to 0.04435211
Phenotype Pichia_Kudriavzevii_1539 20.0321617 .00555307 0.08131335 Decreased 20.0360469 to 0.04634688
Phenotype Pichia_Kudriavzevii_1541 20.0250888 .00638293 0.08131335 Decreased 20.0281781 to 0.0363681
Phenotype Pichia_Kudriavzevii_1540 20.0309761 .00694138 0.08131335 Decreased 20.0348236 to 0.04502356
Phenotype Saccharomyces_1327 20.1066187 .0088887 0.09110916 Decreased 20.1204243 to 0.15702429
Phenotype Aspergillus_flavus_1703 20.2422061 .02612342 0.22469852 Decreased 20.2799263 to 0.37992633
Phenotype Aspergillus_flavus_1631 20.2258779 .02740226 0.22469852 Decreased 20.2615235 to 0.35602348
Phenotype Saccharomycetales_Uncultured_716 20.1691154 .03545843 0.26432651 Decreased 20.1853351 to 0.22833514
Phenotype Saccharomycetales_Uncultured_717 20.1835183 .04168681 0.26766654 Decreased 20.1899307 to 0.20693072
Phenotype Leotiomycetes_Uncultured_1500 20.0163321 .04646276 0.26766654 Decreased 20.0223673 to 0.03836733
Direction of the correlation coefficient is in relation to the control group. P values are corrected for false discovery rate. Boldface represents the same OTUs identified as significant
by using DESeq2 analysis (see Table E3).
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